Alexion Pharmaceuticals Overview
Alexion Pharmaceuticals Target Price
Analysts' 12-month price predictions for ALXN.
Get informed when a big investor buys or sells
+ FollowShare Price
$182.5
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2020-12-16 | Truist FinancialRobyn Karnauskas | $175 |  4.1% downside |  |
| 2020-12-14 | RBC CapitalKennen MacKay | $175 | 4.1% downside | |
| 2020-10-30 | Morgan StanleyMatthew Harrison | $119 | 34.8% downside | |
| 2020-10-29 | JefferiesEun Yang | $120 | 34.2% downside | |
| 2020-10-28 | UBSColin Bristow | $133 | 27.1% downside | |